How Risk-Based Monitoring Redistributes and Reshapes Capacity Planning

Clinical trial monitoring is changing, and with it the assumptions that underpin how organizations resource their clinical research associate (CRA) teams and work with investigative sites. Risk-based quality management (RBQM), remote monitoring, and centralized monitoring have attracted significant industry attention, underpinned by rapid technological advancement, raising questions about how the CRA role will evolve. What receives less focus, however, is the direct consequence these models and tools have for capacity planning. In our experience, monitoring time is not reduced but rather redistributed across roles, locations, and timelines.